May 21st
May 23rd
International course

European Course of in vivo Preclinical Assays in Cancer Therapy

6th edition

In vivo Preclinical Models in cancer

The 6th European Course of in vivo Preclinical Assays in Cancer Therapy is an extensive training program designed to educate and update the biomedical research community on current trends and technological advances in in vivo preclinical assays in cancer.
The emphasis of this course will be on the use of genetically engineered mouse models and patient-derived xenograft (PDX) models for in vivo preclinical research.
The course will cover the following topics: in vitro preclinical assays employing established tumor cell lines and functional genomics approaches, preclinical imaging, angiogenesis and metastasis, Zebrafish model, therapy resistance models and approaches, ethics and co-clinical trials.

Course in English

Practical Informations

Registration fees

Academic : 300€ TVA incluse
Industry : 450€ TVA incluse
(coffee breaks, lunches and  social dinner on Thursday evening included)

Institut Curie
Amphithéâtre Constant-Burg
12 rue Lhomond, 75005 Paris

Maximum Number of Participants

80 people

Number of Participants

The number of participants will be restricted to 80 to promote exchange between participants and speakers.



Virginie Dangles-Marie (Institut Curie), Jos Jonkers (NKI), Elisabetta Marangoni (Institut Curie), Sven Rottenberg (NKI)

Supported by


  • Training Unit - Institut Curie